U.S. FDA issues observation to Aurobindo Pharma arm’s API unit
· 9/15/2026, 3:14:50 PM· 3 min read
Read original story →Related stories
business
RBI files caveat after rejecting Tata Sons bid to avoid listing, source says
business
Amazon Now crosses $1 billion annualised sales in India in 3 months
business
Dr. Reddy’s forays into India’s biosimilar immuno-oncology market, launches Nivorz
business